| 2026 |
| 03/06 | 3,319 | 3,451 | 3,318 | 3,451 | +0.32% | 2,233,700 | 3兆701億 | -0.69% |
| 03/05 | 3,493 | 3,515 | 3,425 | 3,440 | +0.64% | 2,574,700 | 3兆603億 | -0.61% |
| 03/04 | 3,445 | 3,470 | 3,389 | 3,418 | -2.26% | 2,654,800 | 3兆407億 | -0.9% |
| 03/03 | 3,485 | 3,543 | 3,464 | 3,497 | -1.58% | 2,337,500 | 3兆1110億 | +1.75% |
| 03/02 | 3,624 | 3,635 | 3,528 | 3,553 | -3.03% | 2,588,000 | 3兆1608億 | +3.8% |
| 02/27 | （IR情報）13:00 アトピー性皮膚炎治療薬「コレクチム」の国内におけるローション剤の剤形追加に関する製造販売承認申請について |
| 02/27 | 3,644 | 3,687 | 3,616 | 3,664 | +0.44% | 4,718,500 | 3兆2596億 | +7.7% |
| 02/26 | 3,657 | 3,667 | 3,623 | 3,648 | -0.44% | 2,364,500 | 3兆2453億 | +8.22% |
| 02/25 | 3,700 | 3,705 | 3,625 | 3,664 | +0.94% | 2,733,300 | 3兆2596億 | +9.63% |
| 02/24 | 3,666 | 3,666 | 3,574 | 3,630 | -0.41% | 2,844,300 | 3兆2293億 | +9.7% |
| 02/20 | （IR情報）16:30 当社の完全子会社である鳥居薬品株式会社の吸収合併に関する基本方針決定のお知らせ |
| 02/20 | 3,602 | 3,678 | 3,601 | 3,645 | +0.08% | 1,951,700 | 3兆2427億 | +11.16% |
| 02/19 | 3,535 | 3,660 | 3,523 | 3,642 | +1.87% | 2,427,000 | 3兆2400億 | +12.06% |
| 02/18 | 3,512 | 3,577 | 3,506 | 3,575 | +2.82% | 1,814,500 | 3兆1804億 | +10.96% |
| 02/17 | 3,471 | 3,505 | 3,452 | 3,477 | +0.78% | 1,649,700 | 3兆932億 | +8.83% |
| 02/16 | 3,577 | 3,577 | 3,450 | 3,450 | -2.43% | 2,171,800 | 3兆692億 | +8.76% |
| 02/13 | 3,579 | 3,588 | 3,484 | 3,536 | +0.03% | 4,530,400 | 3兆1457億 | +12.22% |
| 02/12 | 3,539 | 3,540 | 3,497 | 3,535 | +1.17% | 2,810,600 | 3兆1448億 | +13.16% |
| 02/10 | 3,527 | 3,560 | 3,494 | 3,494 | -0.77% | 2,783,800 | 3兆1083億 | +12.86% |
| 02/09 | 3,581 | 3,591 | 3,496 | 3,521 | +3.77% | 3,530,800 | 3兆1323億 | +14.65% |
| 02/06 | 3,405 | 3,428 | 3,356 | 3,393 | -1.02% | 2,540,900 | 3兆185億 | +11.47% |
| 02/05 | 3,558 | 3,558 | 3,427 | 3,428 | +1.63% | 3,553,100 | 3兆496億 | +13.47% |
| 02/04 | 3,350 | 3,392 | 3,302 | 3,373 | +0.81% | 2,609,300 | 3兆7億 | +12.51% |
| 02/03 | 3,287 | 3,363 | 3,240 | 3,346 | +4.01% | 3,944,200 | 2兆9767億 | +12.36% |
| 02/02 | 3,291 | 3,291 | 3,217 | 3,217 | +1.35% | 3,162,600 | 2兆8619億 | +8.87% |
| 01/30 | （IR情報）13:00 2026年3月期第3四半期決算短信〔IFRS〕(連結) |
| 01/30 | （IR情報）13:00 2025年度第3四半期決算説明資料 |
| 01/30 | （IR情報）13:00 2026年3月期第3四半期決算〈補足資料) |
| 01/30 | 3,088 | 3,247 | 3,076 | 3,174 | +1.86% | 5,297,000 | 2兆8236億 | +8.03% |
| 01/29 | 3,022 | 3,132 | 3,021 | 3,116 | +1.23% | 3,255,000 | 2兆7720億 | +6.75% |
| 01/28 | 3,092 | 3,138 | 3,078 | 3,078 | -2.29% | 4,420,200 | 2兆7382億 | +6.03% |
| 01/27 | 3,082 | 3,156 | 3,040 | 3,150 | +1.22% | 3,161,800 | 2兆8023億 | +9.03% |
| 01/26 | 3,040 | 3,118 | 3,032 | 3,112 | -1.21% | 4,026,500 | 2兆7685億 | +8.36% |
| 01/23 | 3,051 | 3,150 | 3,033 | 3,150 | +4.13% | 5,044,500 | 2兆8023億 | +10.22% |
| 01/22 | 2,942 | 3,029 | 2,924 | 3,025 | +4.24% | 4,656,500 | 2兆6911億 | +6.44% |
| 01/21 | 2,851 | 2,902 | 2,825 | 2,902 | -0.65% | 3,812,500 | 2兆5817億 | +2.62% |
| 01/20 | 2,925 | 2,949 | 2,860 | 2,921 | +2.82% | 4,123,200 | 2兆5986億 | +3.66% |
| 01/20 | （IR情報）8:30 ViiV Healthcare Ltd.への追加出資による持分法適用関連会社化について |
| 01/19 | 2,850 | 2,860 | 2,828 | 2,841 | -0.77% | 1,683,100 | 2兆5274億 | +1.14% |
| 01/16 | 2,863 | 2,880 | 2,814 | 2,863 | -2.55% | 2,615,000 | 2兆5470億 | +2% |
| 01/15 | 2,969 | 2,983 | 2,926 | 2,938 | -0.14% | 2,512,400 | 2兆6137億 | +4.93% |
| 01/14 | 2,930 | 2,956 | 2,907 | 2,942 | +1.59% | 3,081,800 | 2兆6172億 | +5.49% |
| 01/13 | 2,934 | 2,959 | 2,896 | 2,896 | -0.38% | 3,334,800 | 2兆5763億 | +4.21% |
| 01/09 | 2,909 | 2,918 | 2,867 | 2,907 | -0.62% | 3,729,500 | 2兆5861億 | +5.02% |
| 01/08 | 2,908 | 2,955 | 2,901 | 2,925 | +2.88% | 3,370,500 | 2兆6021億 | +6.06% |
| 01/07 | 2,819 | 2,862 | 2,801 | 2,843 | -0.14% | 3,232,900 | 2兆5292億 | +3.57% |
| 01/06 | 2,852 | 2,867 | 2,839 | 2,847 | -0.63% | 3,261,300 | 2兆5327億 | +3.94% |
| 01/05 | 2,860 | 2,882 | 2,837 | 2,865 | +0.84% | 2,430,000 | 2兆5487億 | +4.83% |
| 2025 |
| 12/30 | 2,832 | 2,844 | 2,822 | 2,841 | +0.28% | 2,200,100 | 2兆5274億 | +4.1% |
| 12/29 | 2,825 | 2,853 | 2,816 | 2,833 | -0.56% | 1,991,500 | 2兆5203億 | +4% |
| 12/26 | 2,870 | 2,884 | 2,833 | 2,849 | -0.35% | 1,943,800 | 2兆5345億 | +4.78% |
| 12/25 | 2,820 | 2,859 | 2,797 | 2,859 | +2.99% | 1,678,800 | 2兆5434億 | +5.34% |
| 12/24 | 2,800 | 2,822 | 2,770 | 2,776 | -0.47% | 2,481,300 | 2兆4696億 | +2.55% |
| 12/23 | 2,740 | 2,795 | 2,733 | 2,789 | +3.11% | 2,808,000 | 2兆4811億 | +3.14% |
| 12/22 | （IR情報）19:00 田辺ファーマからの筋萎縮性側索硬化症等治療薬エダラボン事業の買収に関するお知らせ |
| 12/22 | （IR情報）15:00 うつ病治療薬「ザズベイカプセル30mg」の国内における製造販売承認取得について |
| 12/22 | 2,720 | 2,728 | 2,677 | 2,705 | -0.41% | 1,533,100 | 2兆4064億 | +0.19% |
| 12/19 | 2,735 | 2,736 | 2,708 | 2,716 | -0.84% | 4,115,100 | 2兆4162億 | +0.56% |
| 12/18 | 2,734 | 2,763 | 2,726 | 2,739 | +0.74% | 1,749,300 | 2兆4367億 | +1.37% |
| 12/17 | 2,723 | 2,731 | 2,700 | 2,719 | -1.63% | 2,181,600 | 2兆4189億 | +0.7% |
| 12/16 | 2,742 | 2,785 | 2,740 | 2,764 | +0.8% | 2,493,000 | 2兆4589億 | +2.48% |
| 12/15 | 2,693 | 2,754 | 2,687 | 2,742 | +2.43% | 2,505,900 | 2兆4393億 | +1.86% |
| 12/12 | 2,664 | 2,699 | 2,662 | 2,677 | +0.6% | 3,551,400 | 2兆3815億 | -0.37% |
| 12/11 | 2,674 | 2,676 | 2,651 | 2,661 | -0.63% | 2,305,200 | 2兆3673億 | -0.89% |
| 12/10 | 2,725 | 2,774 | 2,678 | 2,678 | -4.66% | 4,520,600 | 2兆3824億 | -0.15% |
| 12/09 | 2,730 | 2,809 | 2,712 | 2,809 | +4.62% | 3,810,300 | 2兆4989億 | +4.89% |
| 12/08 | 2,685 | 2,730 | 2,671 | 2,685 | +1.24% | 2,679,100 | 2兆3886億 | +0.6% |
| 12/05 | 2,651 | 2,662 | 2,627 | 2,652 | -1.6% | 2,024,600 | 2兆3593億 | -0.34% |
| 12/04 | 2,602 | 2,695 | 2,598 | 2,695 | +2.47% | 2,910,600 | 2兆3975億 | +1.54% |
| 12/03 | 2,618 | 2,635 | 2,603 | 2,630 | -0.38% | 1,737,500 | 2兆3397億 | -0.6% |
| 12/02 | 2,600 | 2,646 | 2,590 | 2,640 | +0.69% | 2,386,100 | 2兆3486億 | 0% |
| 12/01 | （IR情報）16:45 会社分割(簡易吸収分割)による日本たばこ産業株式会社の医薬事業の承継完了に関するお知らせ |
| 12/01 | 2,653 | 2,663 | 2,584 | 2,622 | -2.2% | 2,823,800 | 2兆3326億 | -0.38% |
| 11/28 | （IR情報）15:45 (訂正・数値データ訂正)「2026年3月期第2四半期(中間期)決算短信〔IFRS〕(連結)」の一部訂正について |
| 11/28 | 2,686 | 2,701 | 2,667 | 2,681 | -0.37% | 1,956,700 | 2兆3851億 | +2.09% |
| 11/27 | 2,728 | 2,747 | 2,686 | 2,691 | -2.5% | 1,569,500 | 2兆3940億 | +2.87% |
| 11/26 | 2,718 | 2,770 | 2,705 | 2,760 | +0.99% | 2,636,900 | 2兆4553億 | +5.87% |
| 11/25 | 2,762 | 2,771 | 2,717 | 2,733 | +1.33% | 4,090,100 | 2兆4313億 | +5.36% |
| 11/21 | 2,697 | 2,732 | 2,680 | 2,697 | -0.81% | 4,791,400 | 2兆3993億 | +4.49% |
| 11/20 | 2,700 | 2,768 | 2,700 | 2,719 | +1.12% | 1,979,600 | 2兆4189億 | +5.8% |
| 11/19 | 2,709 | 2,740 | 2,689 | 2,689 | -0.63% | 2,285,800 | 2兆3922億 | +5.12% |
| 11/18 | 2,710 | 2,745 | 2,700 | 2,706 | +0.78% | 2,125,600 | 2兆4073億 | +6.24% |
| 11/17 | 2,720 | 2,736 | 2,681 | 2,685 | -1.76% | 2,806,100 | 2兆3886億 | +5.79% |
| 11/14 | 2,750 | 2,775 | 2,710 | 2,733 | +0.04% | 2,594,800 | 2兆4313億 | +7.94% |
| 11/13 | 2,715 | 2,735 | 2,702 | 2,732 | +1.6% | 1,726,200 | 2兆4304億 | +8.2% |
| 11/12 | 2,696 | 2,758 | 2,683 | 2,689 | +1.55% | 3,018,200 | 2兆3922億 | +6.75% |
| 11/11 | 2,651 | 2,665 | 2,640 | 2,648 | +0.04% | 1,683,100 | 2兆3557億 | +5.25% |
| 11/10 | 2,612 | 2,649 | 2,610 | 2,647 | +1.53% | 1,730,700 | 2兆3548億 | +5.46% |
| 11/07 | 2,605 | 2,630 | 2,595 | 2,607 | -0.65% | 1,725,500 | 2兆3192億 | +4.11% |
| 11/06 | 2,587 | 2,655 | 2,582 | 2,624 | +1.12% | 2,272,800 | 2兆3343億 | +4.88% |
| 11/05 | 2,631 | 2,703 | 2,556 | 2,595 | +0.54% | 4,083,400 | 2兆3085億 | +3.8% |
| 11/04 | 2,591 | 2,608 | 2,545 | 2,581 | +0.04% | 3,307,000 | 2兆2961億 | +3.24% |
| 10/31 | 2,526 | 2,588 | 2,494 | 2,580 | +3.86% | 4,120,700 | 2兆2952億 | +3.12% |
| 10/30 | 2,490 | 2,517 | 2,471 | 2,484 | -0.12% | 7,416,300 | 2兆2098億 | -0.8% |
| 10/29 | 2,493 | 2,545 | 2,453 | 2,487 | -0.28% | 3,599,900 | 2兆2125億 | -0.96% |
| 10/28 | 2,498 | 2,519 | 2,469 | 2,494 | +0.44% | 3,600,500 | 2兆2187億 | -0.91% |
| 10/27 | （IR情報）16:30 資本コストや株価を意識した経営の実現に向けた対応に関するお知らせ |
| 10/27 | （IR情報）15:30 シオノギファーマ株式会社の吸収合併について |
| 10/27 | （IR情報）15:30 2026年3月期第2四半期決算〈補足資料〉 |
| 10/27 | （IR情報）15:30 2026年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) |
| 10/27 | （IR情報）15:30 2025年度第2四半期決算説明会 |
| 10/27 | 2,488 | 2,489 | 2,432 | 2,483 | +1.64% | 3,630,900 | 2兆2089億 | -1.7% |
| 10/24 | 2,467 | 2,475 | 2,443 | 2,443 | -0.33% | 2,233,200 | 2兆1733億 | -3.52% |
| 10/23 | 2,439 | 2,461 | 2,433 | 2,451 | +0.04% | 1,868,600 | 2兆1804億 | -3.47% |
| 10/22 | 2,468 | 2,482 | 2,450 | 2,450 | -0.2% | 1,915,800 | 2兆1795億 | -3.77% |
| 10/21 | 2,454 | 2,479 | 2,454 | 2,455 | +0.37% | 1,796,800 | 2兆1840億 | -3.88% |
| 10/20 | 2,443 | 2,455 | 2,402 | 2,446 | +1.96% | 2,325,000 | 2兆1760億 | -4.53% |
| 10/17 | 2,404 | 2,421 | 2,393 | 2,399 | -0.7% | 2,272,500 | 2兆1342億 | -6.69% |
| 10/16 | 2,459 | 2,459 | 2,408 | 2,416 | -0.08% | 2,058,100 | 2兆1493億 | -6.43% |
| 10/15 | 2,416 | 2,435 | 2,397 | 2,418 | -0.08% | 2,393,700 | 2兆1511億 | -6.75% |
| 10/14 | 2,423 | 2,460 | 2,402 | 2,420 | -2.58% | 3,382,600 | 2兆1529億 | -7.03% |
| 10/10 | 2,526 | 2,541 | 2,462 | 2,484 | -2.24% | 5,754,700 | 2兆2098億 | -4.83% |
| 10/09 | 2,536 | 2,566 | 2,532 | 2,541 | -0.16% | 1,643,600 | 2兆2605億 | -2.83% |
| 10/08 | 2,630 | 2,643 | 2,536 | 2,545 | -1.96% | 2,667,700 | 2兆2641億 | -2.68% |
| 10/07 | 2,614 | 2,624 | 2,583 | 2,596 | -0.12% | 2,059,100 | 2兆3094億 | -0.76% |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
